Open (posted) · Grant
DoW Rare Cancers Idea Development Award
Defense Health Agency Contracting Activity - DHACA, Department of Defense
Key facts
Copied from the official Grants.gov record. Last verified October 30, 2026.
- Program name
- DoW Rare Cancers Idea Development Award
- Issuing agency
- Defense Health Agency Contracting Activity - DHACA (Department of Defense)
- Opportunity number
- HT942526RCRPIDA
- Funding type
- Grant
- Funding purpose
- Science and Technology and other Research and Development
- Status
- Open (posted)
- Application deadline
- Closes November 18, 2026(19 days left)
- Published award range
- Not published by the agency
- Estimated total program funding
- $7,350,000
- Expected number of awards
- 15
- Cost sharing or match required
- No
- Eligible applicants (official categories)
- Unrestricted (open to any type of entity, subject to any clarification in Additional Information on Eligibility)
- Relevant to
- Businesses and NonprofitsHow we determined this: Grants.gov lists eligibility as Unrestricted.
- Geographic restrictions
- None stated in structured data (federal opportunities are often nationwide). Check the eligibility details and full announcement for any limits.
- Assistance Listing (CFDA)
- 12.420
- Official source
- View on Grants.gov ↗
- Application URL
- www.grants.gov/search-results-detail/362849 ↗Apply through Grants.gov (Workspace) using the application package on the official listing, unless the full announcement names a different submission system.
- Source identifier
- Grants.gov opportunity ID 362849 · Funding opportunity number HT942526RCRPIDA
- Posted
- June 17, 2026 · Source last updated June 17, 2026
- Last verified
- October 30, 2026 (against Grants.gov)
- Data completeness
- 83% of key fields published by the sourceNot published: published funding range, eligibility criteria text.
- Record confidence
- highVerified against the official source; key fields present; no open issues.
Description (from the official listing)
Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Idea Development Award (IDA) promotes ideas that are ready for further development and have the potential to yield high-impact findings and new avenues of investigation.Distinctive Features:The RCRP encourages applicants to include an exploratory aim or sub-aim to support any necessary discovery-driven research.Preliminary data with disease-specific rationale are required. However, these data do not necessarily need to originate from studies of the proposed rare cancer type(s)/subtype(s) under study.Research should have high potential impact on rare cancers and the patient community.
Agency contact
eBRAP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org
help@eBRAP.org